Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 12:32 AM
NCT ID:
NCT00120367
Eligibility Criteria:
Inclusion Criteria:
* 18 years of age and older
* Have confirmed laboratory diagnosis of HIV infection
* Presenting with a clinical history of active PML evolving (or continuing to deteriorate) for less than 90 days
* Diagnosis of PML documented for less than 30 days at the inclusion by cerebral imaging (MRI) AND the absence of another demonstrated etiology AND the detection of JCV DNA in the CSF by qualitative PCR.
* Signed written inform consent
Exclusion Criteria:
* Concomitant opportunistic infection of the central nervous system
* Pregnancy, breast-feeding
* Co-infection by the HIV2
* History of immunotherapy including interleukin-2 and alpha-interferon
* History of treatment by FUZEON® or by cidofovir
* Contra-indication to receive FUZEON
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00120367
Study Brief:
Protocol Section:
NCT00120367